DiMarchi, who was a vice president at Eli Lilly and involved in GLP-1 research there, until he left the company in 2003, is that many diseases may share the same root causes, even though we label them and treat them as distinct: This is an endocrine disease, this is a cardiovascular disease, this is a brain disease. This root-cause theory suggests that a wide range of conditions can be treatable with one drug class, sometimes through pathways in the brain and the immune system
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment
Richards et al., 1976
Keep the lid tightly sealed after every use
"But they're clearly going to become a very important part of an integrated approach to obesity," he said
The inactive form is considered a precursor as it gets converted into an active peptide GLP-1 (7-37) by cleaving a single arginine residue (Fig